U.S. EPA Amends MRLs for Multiple Active Ingredients
December 5, 2018

The U.S. EPA recently established tolerances for residues of oxytetracyclinebixafen, clomazone, bifenthrin, and dinotefuran in or on various commodities.

Objections and requests for hearings must be received by February 4, 2019. The amended MRLs will be available in the Global MRL Database on December 6, 2018.

All News Tags